20P Deletions FTNW
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Diversity in the Organization of Centromeric Chromatin
Available online at www.sciencedirect.com ScienceDirect Diversity in the organization of centromeric chromatin 1 Florian A Steiner and Steven Henikoff Centromeric chromatin is distinguished primarily by lacking. In most species, cenH3 nucleosomes assemble nucleosomes containing the histone variant cenH3, which on particular families of tandemly repetitive satellite organizes the kinetochore that links the chromosome to the DNA, and the intractability of long satellite repeat arrays spindle apparatus. Whereas budding yeast have simple ‘point’ has greatly hindered the analysis of centromeric chroma- centromeres with single cenH3 nucleosomes, and fission yeast tin. Recent studies have begun to shed light on these have ‘regional’ centromeres without obvious sequence enigmatic regions of chromosomes, in part through specificity, the centromeres of most organisms are embedded improvements in sequencing technologies and in part in highly repetitive ‘satellite’ DNA. Recent studies have revealed through analysis of model systems that circumvent the a remarkable diversity in centromere chromatin organization challenges presented by the repeat-richness of most among different lineages, including some that have lost cenH3 higher eukaryotic centromeres. The emerging picture altogether. We review recent progress in understanding point, shows that cenH3 is incorporated into well-positioned regional and satellite centromeres, as well as less well-studied nucleosomes at centromeres that are distinct from canon- centromere types, such as holocentromeres. -
5885.Full.Pdf
Research Article 5885 Assembly of additional heterochromatin distinct from centromere-kinetochore chromatin is required for de novo formation of human artificial chromosome Hiroshi Nakashima1,2,3, Megumi Nakano1,*, Ryoko Ohnishi1, Yasushi Hiraoka4, Yasufumi Kaneda2, Akio Sugino1,3 and Hiroshi Masumoto1,*,‡ 1Division of Biological Science, Graduate School of Science, Nagoya University, Chikusa-ku, Nagoya 464-8602, Japan 2Division of Gene Therapy Science, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan 3Laboratories for Biomolecular Networks, Graduate School of Frontier Biosciences, Osaka University, 1-3 Yamada-oka, Suita, Osaka 565-0871, Japan 4Kansai Advanced Research Center, National Institute of Information and Communications Technology, 588-2 Iwaoka, Iwaoka-cho, Nishi-ku, Kobe 651-2492, Japan *Present address: Laboratory of Biosystems and Cancer, National Cancer Institute, National Institutes of Health, Bldg. 37, Rm 5040, 9000 Rockville Pike, Bethesda, MD 20892, USA ‡Author for correspondence (e-mail: [email protected]) Accepted 20 September 2005 Journal of Cell Science 118, 5885-5898 Published by The Company of Biologists 2005 doi:10.1242/jcs.02702 Summary Alpha-satellite (alphoid) DNA is necessary for de novo arms. However, on the stable HAC, chromatin formation of human artificial chromosomes (HACs) in immunoprecipitation analysis showed that HP1␣ and human cultured cells. To investigate the relationship trimethyl histone H3-K9 were enriched at the non- among centromeric, transcriptionally -
In Vitro Analysis of Mutations Causing Myoclonus Epilepsy with Ragged-Red Fibers in the Mitochondrial Trnalys Gene: Two Genotypes Produce Similar Phenotypes JUDY P
MOLECULAR AND CELLULAR BIOLOGY, May 1995, p. 2872–2881 Vol. 15, No. 5 0270-7306/95/$04.0010 Copyright q 1995, American Society for Microbiology In Vitro Analysis of Mutations Causing Myoclonus Epilepsy with Ragged-Red Fibers in the Mitochondrial tRNALys Gene: Two Genotypes Produce Similar Phenotypes JUDY P. MASUCCI,1 MERCY DAVIDSON,2 YASUTOSHI KOGA,2† 1,2 2 ERIC A. SCHON, AND MICHAEL P. KING * Departments of Genetics and Development1 and Neurology,2 Columbia University, New York, New York 10032 Received 6 December 1994/Returned for modification 20 January 1995/Accepted 20 February 1995 Cytoplasts from patients with myoclonus epilepsy with ragged-red fibers harboring a pathogenic point mutation at either nucleotide 8344 or 8356 in the human mitochondrial tRNALys gene were fused with human cells lacking endogenous mitochondrial DNA (mtDNA). For each mutation, cytoplasmic hybrid (cybrid) cell lines containing 0 or 100% mutated mtDNAs were isolated and their genetic, biochemical, and morphological characteristics were examined. Both mutations resulted in the same biochemical and molecular genetic phenotypes. Specifically, cybrids containing 100% mutated mtDNAs, but not those containing the correspond- ing wild-type mtDNAs, exhibited severe defects in respiratory chain activity, in the rates of protein synthesis, and in the steady-state levels of mitochondrial translation products. In addition, aberrant mitochondrial translation products were detected with both mutations. No significant alterations were observed in the processing of polycistronic RNA precursor transcripts derived from the region containing the tRNALys gene. These results demonstrate that two different mtDNA mutations in tRNALys, both associated with the same mitochondrial disorder, result in fundamentally identical defects at the cellular level and strongly suggest that specific protein synthesis abnormalities contribute to the pathogenesis of myoclonus epilepsy with ragged-red fibers. -
Aneuploidy and Aneusomy of Chromosome 7 Detected by Fluorescence in Situ Hybridization Are Markers of Poor Prognosis in Prostate Cancer'
[CANCERRESEARCH54,3998-4002,August1, 19941 Advances in Brief Aneuploidy and Aneusomy of Chromosome 7 Detected by Fluorescence in Situ Hybridization Are Markers of Poor Prognosis in Prostate Cancer' Antonio Alcaraz, Satoru Takahashi, James A. Brown, John F. Herath, Erik J- Bergstralh, Jeffrey J. Larson-Keller, Michael M Lieber, and Robert B. Jenkins2 Depart,nent of Urology [A. A., S. T., J. A. B., M. M. U, Laboratory Medicine and Pathology (J. F. H., R. B. fl, and Section of Biostatistics (E. J. B., J. J. L-JCJ, Mayo Clinic and Foundation@ Rochester, Minnesota 55905 Abstract studies on prostate carcinoma samples. Interphase cytogenetic analy sis using FISH to enumerate chromosomes has the potential to over Fluorescence in situ hybridization is a new methodologj@which can be come many of the difficulties associated with traditional cytogenetic used to detect cytogenetic anomalies within interphase tumor cells. We studies. Previous studies from this institution have demonstrated that used this technique to identify nonrandom numeric chromosomal alter ations in tumor specimens from the poorest prognosis patients with path FISH analysis with chromosome enumeration probes is more sensitive ological stages T2N@M,Jand T3NOMOprostate carcinomas. Among 1368 than FCM for detecting aneuploid prostate cancers (4, 5, 7). patients treated by radical prostatectomy, 25 study patients were ascer We designed a case-control study to test the hypothesis that spe tamed who died most quickly from progressive prostate carcinoma within cific, nonrandom cytogenetic changes are present in tumors removed 3 years of diagnosis and surgery. Tumors from 25 control patients who from patients with prostate carcinomas with poorest prognoses . -
Centromere Chromatin: a Loose Grip on the Nucleosome?
CORRESPONDENCE Stanford, California, USA. 7. Black, B.E. et al. Nature 430, 578–582 (2004). Natl. Acad. Sci. USA 104, 15974–15981 (2007). e-mail: [email protected] 8. Walkiewicz, M.P., Dimitriadis, E.K. & Dalal, Y. Nat. 16. Godde, J.S. & Wolffe, A.P.J. Biol. Chem. 270, 27399– Struct. Mol. Biol. 21, 2–3 (2014). 27402 (1995). 1. Dalal, Y., Wang, H., Lindsay, S. & Henikoff, S. PLoS 9. Codomo, C.A., Furuyama, T. & Henikoff, S. Nat. Struct. 17. de Frutos, M., Raspaud, E., Leforestier, A. & Livolant, F. Biol. 5, e218 (2007). Mol. Biol. 21, 4–5 (2014). Biophys. J. 81, 1127–1132 (2001). 2. Dimitriadis, E.K., Weber, C., Gill, R.K., Diekmann, S. 10. Yoda, K. et al. Proc. Natl. Acad. Sci. USA 97, 7266– 18. Gansen, A. et al. Proc. Natl. Acad. Sci. USA 106, & Dalal, Y. Proc. Natl. Acad. Sci. USA 107, 20317– 7271 (2000). 15308–15313 (2009). 20322 (2010). 11. Tomschik, M., Karymov, M.A., Zlatanova, J. & Leuba, S.H. 19. Zhang, W., Colmenares, S.U. & Karpen, G.H. Mol. Cell 3. Bui, M. et al. Cell 150, 317–326 (2012). Structure 9, 1201–1211 (2001). 45, 263–269 (2012). 4. Furuyama, T., Codomo, C.A. & Henikoff, S. Nucleic 12. Bui, M., Walkiewicz, M.P., Dimitriadis, E.K. & Dalal, Y. 20. Tachiwana, H. et al. Nature 476, 232–235 (2011). Acids Res. 41, 5769–5783 (2013). Nucleus 4, 37–42 (2013). 21. Hasson, D. et al. Nat. Struct. Mol. Biol. 20, 687–695 5. Dunleavy, E.M., Zhang, W. & Karpen, G.H. -
Chromosome 20
Chromosome 20 ©Chromosome Disorder Outreach Inc. (CDO) Technical genetic content provided by Dr. Iosif Lurie, M.D. Ph.D Medical Geneticist and CDO Medical Consultant/Advisor. Ideogram courtesy of the University of Washington Department of Pathology: ©1994 David Adler.hum_20.gif Introduction Chromosome 20 contains about 2% of the whole genetic material. Its genetic length is ~63 Mb. The long arm (~36 Mb) is a little bit larger than the short arm (~27 Mb). Chromosome 20 contains ~700–800 genes. Less than 10% of these genes are known to be related to human diseases. Deletions or duplications of these genes, which may be found in patients with chromosomal abnormalities, cause mostly functional defects, including a delay of psycho–motor development and seizures. Only a few genes may lead (when deleted) to structural defects of the heart, liver, extremities and other organs. Deletions of Chromosome 20 There is a relatively small number of known conditions caused by deletions and duplications of various segments of chromosome 20. Almost all of these deletions and duplications became recognized after usage of molecular cytogenetics. Only a handful of reports on patients with these abnormalities were available only 10 years ago. Because these methods open wide an opportunity to examine abnormalities of this previously not–well studied chromosome, there are no doubts that some new syndromes caused by deletions (or duplications) of chromosome 20 will be delineated in the near future. Currently, the most frequent forms of chromosome 20 deletions are deletions 20p12, involving the JAG1 gene and Alagille syndrome, and deletions 20q13.13q13.2, involving the SALL4 gene. -
20Q13.2-Q13.33 Deletion Syndrome: a Case Report
Journal of Pediatric Genetics 2 (2013) 157–161 157 DOI 10.3233/PGE-13065 IOS Press Case Report 20q13.2-q13.33 deletion syndrome: A case report Merlin G. Butlera,*, Kelly M. Usreya, Jennifer L. Robertsa, Ann M. Manzardoa and Stephen R. Schroederb aDepartments of Psychiatry & Behavioral Sciences and Pediatrics, University of Kansas Medical Center, Kansas City, KS, USA bKansas University Center on Developmental Disabilities, Schiefelbusch Institute for Life Span Studies, University of Kansas, Lawrence, KS, USA Received 15 August 2013 Revised 6 September 2013 Accepted 4 October 2013 Abstract. We report a 32-month-old female of Peruvian ethnicity identified with a rare 20q13.2-q13.33 deletion using microarray analysis. She presented with intellectual disability, absent speech, hypotonia, pre- and post-natal growth retardation and an abnor- mal face with a unilateral cleft lip. Clinical features and genetic findings with the loss of 30 genes, including GNAS, MC3R, CDH4 and TFAP2C, are described in relationship to the very few cases of 20q13 deletion reported in the literature. Deletion of this region may play an important role in neurodevelopment and function and in causing specific craniofacial features. Keywords: Microarray analysis, 20q13 deletion, intellectual disability, atypical development, dysmorphic features, cleft lip 1. Introduction (high forehead, broad nasal bridge, thin upper lip, small chin, hypertelorism and malformed ears) [6–10]. Deletions of the long arm of chromosome 20 are rare Herein, we report another individual with the rare with the ring chromosome 20 being the most com- 20q13.2-q13.33 interstitial deletion (7.3 Mb in size) monly reported anomaly with over 100 cases in the and the first detected using chromosomal microarray literature. -
Stem Cells® Original Article
® Stem Cells Original Article Properties of Pluripotent Human Embryonic Stem Cells BG01 and BG02 XIANMIN ZENG,a TAKUMI MIURA,b YONGQUAN LUO,b BHASKAR BHATTACHARYA,c BRIAN CONDIE,d JIA CHEN,a IRENE GINIS,b IAN LYONS,d JOSEF MEJIDO,c RAJ K. PURI,c MAHENDRA S. RAO,b WILLIAM J. FREEDa aCellular Neurobiology Research Branch, National Institute on Drug Abuse, Department of Health and Human Services (DHHS), Baltimore, Maryland, USA; bLaboratory of Neuroscience, National Institute of Aging, DHHS, Baltimore, Maryland, USA; cLaboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA; dBresaGen Inc., Athens, Georgia, USA Key Words. Embryonic stem cells · Differentiation · Microarray ABSTRACT Human ES (hES) cell lines have only recently been compared with pooled human RNA. Ninety-two of these generated, and differences between human and mouse genes were also highly expressed in four other hES lines ES cells have been identified. In this manuscript we (TE05, GE01, GE09, and pooled samples derived from describe the properties of two human ES cell lines, GE01, GE09, and GE07). Included in the list are genes BG01 and BG02. By immunocytochemistry and reverse involved in cell signaling and development, metabolism, transcription polymerase chain reaction, undifferenti- transcription regulation, and many hypothetical pro- ated cells expressed markers that are characteristic of teins. Two focused arrays designed to examine tran- ES cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1- scripts associated with stem cells and with the 81, and OCT-3/4. Both cell lines were readily main- transforming growth factor-β superfamily were tained in an undifferentiated state and could employed to examine differentially expressed genes. -
Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer
Published OnlineFirst July 11, 2011; DOI: 10.1158/0008-5472.CAN-10-3823 Cancer Therapeutics, Targets, and Chemical Biology Research Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer Barbara Stefanska1, Jian Huang4, Bishnu Bhattacharyya1, Matthew Suderman1,2, Michael Hallett3, Ze-Guang Han4, and Moshe Szyf1,2 Abstract We use hepatic cellular carcinoma (HCC), one of the most common human cancers, as a model to delineate the landscape of promoter hypomethylation in cancer. Using a combination of methylated DNA immunopre- cipitation and hybridization with comprehensive promoter arrays, we have identified approximately 3,700 promoters that are hypomethylated in tumor samples. The hypomethylated promoters appeared in clusters across the genome suggesting that a high-level organization underlies the epigenomic changes in cancer. In normal liver, most hypomethylated promoters showed an intermediate level of methylation and expression, however, high-CpG dense promoters showed the most profound increase in gene expression. The demethylated genes are mainly involved in cell growth, cell adhesion and communication, signal transduction, mobility, and invasion; functions that are essential for cancer progression and metastasis. The DNA methylation inhibitor, 5- aza-20-deoxycytidine, activated several of the genes that are demethylated and induced in tumors, supporting a causal role for demethylation in activation of these genes. Previous studies suggested that MBD2 was involved in demethylation of specific human breast and prostate cancer genes. Whereas MBD2 depletion in normal liver cells had little or no effect, we found that its depletion in human HCC and adenocarcinoma cells resulted in suppression of cell growth, anchorage-independent growth and invasiveness as well as an increase in promoter methylation and silencing of several of the genes that are hypomethylated in tumors. -
CENP-B ANTIGEN AROTEC CENP-B Product Info.Pdf Version/Date: A/08.04.09 ATC02-02 CENP-B Antigen 0.20 Mg ATC02-10 CENP-B Antigen 1.0 Mg ______
CENP-B ANTIGEN AROTEC_CENP-B_Product_Info.pdf Version/Date: A/08.04.09 ATC02-02 CENP-B antigen 0.20 mg ATC02-10 CENP-B antigen 1.0 mg _________________________________________________________________________________ Description of the Product 2. Coat ELISA plates with 100 µl of diluted antigen per well. Cover and incubate 24 hours at +4oC. Purified recombinant full-length human sequence protein. After 3. Empty the plates and remove excess liquid by tapping on a coating onto ELISA plates the product will bind autoantibodies to paper towel. CENP-B. 4. Block excess protein binding sites by adding 200 µl PBS containing 1% BSA per well. Cover and incubate at +4oC Purity: The CENP-B autoantigen (80 kDa) is more than 90% overnight. pure, as assessed by SDS-polyacrylamide gel electrophoresis. 5. Empty plates and apply 100 µl of serum samples diluted 1:100 in PBS / 1% BSA / 1% casein / 0.1% Tween 20. Incubate at room temperature for 1 hour. Storage: Store at -65oC or below (long term). Avoid repeated 6. Empty plates and add 200 µl PBS / 0.1% Tween 20 per freezing and thawing. Mix thoroughly before use. well. Incubate 5 minutes then empty plates. Repeat this step twice. Clinical and Biochemical Data 7. Apply 100 µl anti-human IgG-enzyme conjugate (horseradish peroxidase or alkaline phosphatase) diluted in Autoantibodies to centromeric proteins in the sera of patients PBS / 1% BSA / 1% casein / 0.1% Tween 20 per well and with scleroderma were first described in 19801. Subsequent incubate for 1 hour. studies confirmed that anti-centromere antibodies (ACA) were 8. -
RNA Interference, Heterochromatin, and Centromere Function
46_Symp69_Allshire_p.389_396 4/21/05 10:34 AM Page 389 RNA Interference, Heterochromatin, and Centromere Function R.C. ALLSHIRE Wellcome Trust Centre for Cell Biology, University of Edinburgh, The King’s Buildings, Edinburgh EH9 3JR, Scotland, United Kingdom The centromere regions of most eukaryotic metaphase poacetylated state is important for centromere integrity chromosomes are distinctive. The narrower, more com- and function (Ekwall et al. 1997). pact appearance of these regions reflects two important The formation of a functional centromere and kineto- related features: centromeric cohesion and extensive chore assembly requires at least one outer repeat and a blocks of heterochromatin. First, sister centromeres re- central core region (Takahashi et al. 1992; Marschall and main associated because the cohesin complex remains in- Clarke 1995; Ngan and Clarke 1997). The central core tact at centromeres until anaphase. Second, the chromatin alone is unable to be packaged in unusual chromatin coating these regions is very different since they remain when replicated on an extrachromosomal plasmid or condensed throughout the cell cycle and are clearly visi- other sites in the genome or when replicated in Saccha- ble as the most concentrated foci of DNA in interphase romyces cerevisiae (Polizzi and Clarke 1991; Takahashi cells; this has been termed heterochromatin (Bernard and et al. 1992). Thus, this “unusual” CENP-A chromatin is Allshire 2002). not specified by the underlying DNA sequence within It has been known for many years that marker genes this region alone, but it must be induced by the context in placed close to or within such centromeric heterochro- which these sequences are placed. -
The Genomic Landscape of Centromeres in Cancers Anjan K
www.nature.com/scientificreports OPEN The Genomic Landscape of Centromeres in Cancers Anjan K. Saha 1,2,3, Mohamad Mourad3, Mark H. Kaplan3, Ilana Chefetz4, Sami N. Malek3, Ronald Buckanovich5, David M. Markovitz2,3,6,7 & Rafael Contreras-Galindo3,4 Received: 8 March 2019 Centromere genomics remain poorly characterized in cancer, due to technologic limitations in Accepted: 23 July 2019 sequencing and bioinformatics methodologies that make high-resolution delineation of centromeric Published: xx xx xxxx loci difcult to achieve. We here leverage a highly specifc and targeted rapid PCR methodology to quantitatively assess the genomic landscape of centromeres in cancer cell lines and primary tissue. PCR- based profling of centromeres revealed widespread heterogeneity of centromeric and pericentromeric sequences in cancer cells and tissues as compared to healthy counterparts. Quantitative reductions in centromeric core and pericentromeric markers (α-satellite units and HERV-K copies) were observed in neoplastic samples as compared to healthy counterparts. Subsequent phylogenetic analysis of a pericentromeric endogenous retrovirus amplifed by PCR revealed possible gene conversion events occurring at numerous pericentromeric loci in the setting of malignancy. Our fndings collectively represent a more comprehensive evaluation of centromere genetics in the setting of malignancy, providing valuable insight into the evolution and reshufing of centromeric sequences in cancer development and progression. Te centromere is essential to eukaryotic biology due to its critical role in genome inheritance1,2. Te nucleic acid sequences that dominate the human centromeric landscape are α-satellites, arrays of ~171 base-pair monomeric units arranged into higher-order arrays throughout the centromere of each chromosome3–103 1–3.